Latest news with #seniorNotes
Yahoo
7 days ago
- Business
- Yahoo
FORVIA TO OFFER AN ADDITIONAL EUR 200 MILLION OF SENIOR NOTES DUE 2030
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1993, AS AMENDED (THE 'SECURITIES ACT')) OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE US VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT. NANTERRE (FRANCE)JUNE 3, 2025 FORVIA TO OFFER AN ADDITIONAL EUR 200 MILLION OF SENIOR NOTES DUE 2030 FORVIA has announced today that it will make an offering of EUR 200 million in aggregate principal amount of senior notes due 2030 (the 'New Notes') to be consolidated and form a single series with the existing EUR 750 million in aggregate principal amount of senior notes due 2030 issued on March 24, 2025 after the expiry of a 40-day distribution compliance period. The completion of the offering of the New Notes is subject to market conditions. FORVIA intends to use the proceeds of the offering of the New Notes to fund the repurchase of FORVIA's outstanding 2.750% Sustainability-Linked Notes due 2027 (the '2027 Sustainability-Linked Notes') in a cash tender offer (the 'Tender Offer') and pay fees and expenses incurred in connection therewith, including net premiums and accrued and unpaid interest on the 2027 Sustainability-Linked Notes, and fees and expenses incurred in connection with the offering of the New Notes. The Tender Offer launches today and remains subject to conditions, such as the completion of the offering of the New Notes. FORVIA plans to repurchase the 2027 Sustainability-Linked Notes in an amount expected to be equal to the principal amount of the New Notes. The final amount of 2027 Sustainability-Linked Notes accepted in the Tender Offer will be subject to the final amounts of tenders received. IMPORTANT NOTICE This document is not an offer of securities for sale in the United States. The notes being offered by Forvia (the 'New Notes") may not be sold in the United States unless they are registered under the Securities Act or are exempt from registration. The offering of New Notes described in this announcement has not been and will not be registered under the Securities Act, and accordingly any offer or sale of New Notes may be made only in a transaction exempt from the registration requirements of the Securities Act. Nothing herein shall be construed as an offer to purchase or a solicitation of an offer to sell or buy any notes, including the 2027 Sustainability-Linked Notes. Nothing herein constitutes a notice of redemption for the 2027 Sustainability-Linked Notes. It may be unlawful to distribute this document in certain jurisdictions. This document is not for distribution in Canada, Japan or Australia. The information in this document does not constitute an offer of securities for sale in Canada, Japan or Australia. Promotion of the New Notes in the United Kingdom is restricted by the Financial Services and Markets Act 2000 (the 'FSMA'), and accordingly, the New Notes are not being promoted to the general public in the United Kingdom. This announcement is directed solely at (i) persons located outside the United Kingdom, (ii) persons with professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the 'Order'), (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order and (iv) persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) in connection with the issue or sale of any securities of the Issuer or any member of its group may otherwise lawfully be communicated or caused to be communicated (all such persons in (i) – (iv) above being 'relevant persons'). Any investment activity to which this announcement relates will only be available to and will only be engaged with relevant persons. Any person who is not a relevant person should not act or rely on this announcement. The offer and sale of the New Notes will be made pursuant to an exemption under the Prospectus Regulation from the requirement to produce a prospectus for offers of securities. This announcement does not constitute a prospectus within the meaning of the Regulation EU 2017/1129, as amended (the "Prospectus Regulation") or an offer to the public. The offer and sale of the New Notes will be made pursuant to an exemption under the UK Prospectus Regulation from the requirement to produce a prospectus for offers of securities. This announcement does not constitute a prospectus within the meaning of the Prospectus Regulation as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the 'UK Prospectus Regulation') or an offer to the public. MiFID II professionals/ECPs-only/No PRIIPs KID – Manufacturer target market (MIFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as the New Notes are not available to retail investors in EEA. MiFIR professionals/ECPs-only/No UK PRIIPs KID – Manufacturer target market (UK MIFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No UK PRIIPs key information document (KID) has been prepared as the New Notes are not available to retail investors in the UK. Neither the content of Forvia's website nor any website accessible by hyperlinks on Forvia'swebsite is incorporated in, or forms part of, this announcement. The distribution of thisannouncement into any jurisdiction may be restricted by law. Persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction. No money, securities or other consideration is being solicited, and, if sent in response to the information contained herein, no money, securities or other consideration will be accepted. Attachment 20250603 FORVIA TO OFFER AN ADDITIONAL EUR 200 MILLION OF SENIOR NOTES DUE 2030Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
19-05-2025
- Business
- Yahoo
Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes
TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ('Teva') announced today its intention to issue $2,000,000,000 (equivalent) of senior notes through its special purpose finance subsidiaries. Teva Pharmaceutical Finance Netherlands II B.V. ('Teva Finance II') intends to offer EUR-denominated Senior Notes (the 'Euro Notes') and Teva Pharmaceutical Finance Netherlands III B.V. ('Teva Finance III') and Teva Pharmaceutical Finance Netherlands IV B.V. ('Teva Finance IV' and, together with Teva Finance II and Teva Finance III, the 'Issuers') intend to offer USD-denominated Senior Notes (the 'USD Notes' and, together with the Euro Notes, the 'Notes'). The offering is subject to, among other things, market conditions. Teva expects to use the net proceeds from the offerings, together with cash on hand, (i) to fund the announced tender offers to purchase, for cash, its USD 3.150% Senior Notes due 2026, USD 4.750% Sustainability-Linked Senior Notes due 2027, EUR 3.750% Sustainability-Linked Senior Notes due 2027, USD 7.875% Sustainability-Linked Senior Notes due 2029, EUR 7.375% Sustainability-Linked Senior Notes due 2029 and USD 8.125% Sustainability-Linked Senior Notes due 2031 for a maximum combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2,000,000,000 (equivalent), (ii) to pay fees and expenses in connection therewith and (iii) to the extent of any remaining proceeds, the repayment of outstanding debt upon maturity, tender offer or earlier redemption. Net proceeds may be temporarily invested pending application for their stated purpose. Nothing in this press release constitutes an offer to purchase or a solicitation of an offer to sell any of the tender offer notes. The tender offers are being made solely by the offer to purchase dated May 19, 2025. The Notes will be unsecured senior obligations of the Issuers and will be unconditionally guaranteed on a senior basis by Teva. The offering and sale of the Notes will be made pursuant to our effective automatic shelf registration statement on Form S-3, including our base prospectus, filed with the Securities and Exchange Commission (the 'SEC') on February 7, 2025. The offering of these Notes will be made only by means of a prospectus supplement and accompanying base prospectus, which have been filed with the SEC. Before you invest, you should read the prospectus supplement and accompanying prospectus along with other documents that Teva has filed with the SEC and that are incorporated by reference into the prospectus supplement and accompanying base prospectus for more complete information about Teva and this offering. These documents are available at no charge by visiting EDGAR on the SEC website at Alternatively, a copy of the prospectus supplement and accompanying base prospectus related to this offering may be obtained, when available, by contacting BNP PARIBAS, 16, boulevard des Italiens, 75009 Paris, France, Attention: High Yield Desk (email: BNP Paribas Securities Corp., 787 Seventh Avenue, New York, New York 10019, United States of America, Attention: Syndicate Desk (email: BofA Securities Europe SA, 51 rue La Boétie, 75008 Paris, France, Attention: High Yield Syndicate Desk (Tel: +33 18 770 0000, email: levfin_hy_paris@ BofA Securities, NC1-004-03- 43, 200 North College Street, 3rd Floor, Charlotte NC 28255-0001, Attention: Prospectus Department, or by email: at HSBC Continental Europe, 38, avenue Kléber, 75116 Paris, France, Attention: DAJ Global Banking, email: HSBC Bank plc, 8 Canada Square, London E14 5HQ, United Kingdom, Attention: Head of DCM Legal, email: Intesa Sanpaolo S.p.A., Divisione IMI Corporate & Investment Banking, Via Manzoni, 4 – 20121, Milan, Italy, Attention: DCM HY Intesa Sanpaolo, email: or J.P. Morgan SE, Taunustor 1 (TaunusTurm), 60310 Frankfurt am Main, Germany, Attention: Head of EMEA Capital Markets Group, email: Head_of_EMEA_DCMG@ This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, Teva's commitment to bettering health has never wavered. Today, the company's global network of capabilities enables its 37,000 employees across 57 markets to advance health by developing medicines for the future while championing the production of generics and biologics. We are dedicated to addressing patients' needs, now and in the future. Moving forward together with science that treats, inspired by the people we serve. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: completion of the offering of senior notes and tender offer for certain outstanding notes; our substantial indebtedness, which may limit our ability to incur additional indebtedness, engage in additional transactions or make new investments, and may result in a further downgrade of our credit ratings; our inability to raise debt or borrow funds in amounts or on terms that are favorable to us; and other factors discussed in our Quarterly Report on Form 10-Q for the first quarter of 2025 and in our Annual Report on Form 10-K for the year ended December 31, 2024, including the sections thereof captioned 'Risk Factors' and 'Forward Looking Statements,' and other filings with the SEC, which are available at Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements. No assurance can be given that the transactions described herein will be consummated or as to the ultimate terms of any such transactions. It may be unlawful to distribute this press release in certain jurisdictions. This press release is not for distribution in Canada, Japan or Australia. The information in this press release does not constitute an offer of securities for sale in Canada, Japan or Australia. The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area ('EEA'). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, 'MiFID II'); or (ii) a customer within the meaning of Directive 2016/97/EU (as amended, the 'Insurance Distribution Directive'), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129. Consequently, no key information document required by Regulation (EU) No 1286/2014 (as amended, the 'PRIIPs Regulation') for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investors in the United Kingdom. For these purposes, a retail investor means a person who is one (or more) of the following persons: (i) a retail client as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 ('EUWA'); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 as amended (the 'FSMA') and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA; or (iii) not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the 'UK PRIIPs Regulation') for offering or selling the Notes or otherwise making them available to retail investors in the United Kingdom has been prepared and, therefore, offering or selling the Notes or otherwise making them available to any retail investor in the United Kingdom may be unlawful under the UK PRIIPs Regulation. Promotion of the Notes in the United Kingdom is restricted by the FSMA, and accordingly, the Notes are not being promoted to the general public in the United Kingdom. This announcement is for distribution only to, and is only directed at, persons who (i) persons who are outside the United Kingdom or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the 'Order'), (iii) high net worth entities, and other persons to whom they may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order or (iv) persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) in connection with the issue or sale of any notes may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as 'relevant persons'). The Notes will only be available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such Notes will be engaged in only with, relevant persons. This announcement is directed only at relevant persons and must not be acted on or relied on by anyone who is not a relevant person. The notes have not, may not and will not be offered, sold or delivered in the Netherlands, other than to qualified investors (as defined in Regulation (EU) 2017/1129). The Notes have not, may not and will not be offered, sold or delivered in Israel, other than to persons who qualify as one of the types of investors listed in the First Addendum to the Israeli Securities Law, subject to and in accordance with the requirements set forth in the First Addendum to the Israeli Securities Law. Teva Media Inquiries:TevaCommunicationsNorthAmerica@ Teva Investor Relations InquiresTevaIR@
Yahoo
06-05-2025
- Business
- Yahoo
TWO Announces Pricing of Public Offering of Senior Notes
NEW YORK, May 06, 2025--(BUSINESS WIRE)--TWO (Two Harbors Investment Corp, NYSE: TWO) (the "Company"), an MSR-focused REIT, today announced the pricing of an underwritten public offering of $100 million aggregate principal amount of its 9.375% senior notes due 2030 (the "Notes"). The Notes will be issued in minimum denominations of $25 and integral multiples of $25 in excess thereof. TWO has granted the underwriters a 30-day option to purchase up to an additional $15 million aggregate principal amount of the Notes to cover over-allotments. The offering is expected to close on May 13, 2025, subject to the satisfaction of customary closing conditions. The Company intends to apply to list the Notes on the New York Stock Exchange ("NYSE") and, if the application is approved, expects trading in the Notes on NYSE to begin within 30 days after the Notes are first issued. The Company intends to use the net proceeds of the offering for general corporate purposes which may include, among other things, the refinancing or repayment of debt, including the Company's 6.25% senior notes due 2026 and MSR financing, the purchase of the Company's target assets, including MSR, Agency RMBS and other financial assets, in each case subject to the Company's investment guidelines, the repurchase or redemption of the Company's common and preferred equity securities, and other capital expenditures. The Notes will be senior unsecured obligations of the Company and pay interest quarterly in cash on February 15, May 15, August 15 and November 15 of each year, commencing August 15, 2025. The Notes will mature on August 15, 2030, and may be redeemed, in whole or in part, at any time, or from time to time, at TWO's option on or after May 15, 2027. Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, Piper Sandler & Co., RBC Capital Markets, LLC, UBS Investment Bank and Wells Fargo Securities, LLC acted as joint book-running managers of the offering. The offering was made pursuant to the Company's existing shelf registration statement, which was declared effective by the Securities and Exchange Commission (the "SEC") on February 22, 2024. The offering of these securities was made only by means of a prospectus and a related prospectus supplement, which will be filed with the SEC and available on the SEC's website at Copies of the prospectus and prospectus supplement related to this offering may also be obtained, when available, by contacting: Morgan Stanley & Co. LLC at 180 Varick St., 2nd Floor, New York, New York 10014, Attention: Prospectus Department, or by telephone: 1-800-584-6837 (Toll-Free); Goldman Sachs & Co. LLC, at 200 West Street, New York, New York 10282, Attention: Prospectus Department, or by telephone: 866-471-2526, or by email: prospectus-ny@ Piper Sandler & Co., at 1251 Avenue of the Americas, 6th Floor, New York, New York 10020, Attention: Debt Capital Markets, or by email: fsg-dcm@ RBC Capital Markets, LLC at Brookfield Place, 200 Vesey Street, 8th Floor, New York, New York 10281, or by telephone: 1-866-375-6829 (Toll-Free), or by email: rbcnyfixedincomeprospectus@ UBS Investment Bank, 1285 Avenue of the Americas, New York, New York 10019, Attention: Prospectus Department, or by telephone: (833) 481-0269; or Wells Fargo Securities, LLC at 608 2nd Avenue South, Suite 1000, Minneapolis, Minnesota 55402, Attention: WFS Customer Service, or by telephone: 1-800-645-3751 (Toll-Free) or by email: wfscustomerservice@
